Objective: The objective of this research was to develop and validate a simple, sensitive and specific Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS) quantification of Gabapentin in human plasma. The analytical method consists of liquid-liquid extraction of plasma sample followed by the determination of Gabapentin by a LC–MS/MS.

Method: The analyte was separated on a Zorbax Eclipse XDB -C18 (150 x 4.6 mm, 5 µ) column with an isocratic mobile phase of Methanol: Water (50: 50 v/v, pH of 3.0) at a flow rate of 0.8 mL/min. Protonated ions formed by a turbo ionspray in a positive mode was used to detect analyte and internal standard (IS). The MS/MS detection was made by monitoring the fragmentation of m/z 172.20→154.20 for Gabapentin and m/z 176.40→158.10 for internal standard on a mass spectrometer.

Results: The method was validated over the concentration range of 51.356 ng/mL to 8217.008 ng/mL for Gabapentin in human plasma with correlation coefficient greater than 0.98.

Conclusion: The developed method was successfully applied for analyzing Gabapentin in plasma samples for a bioequivalence study with healthy volunteers.


Key words: Gabapentin; Validation; Analysis; Bioavailability; LC-MS/MS.

Author Biography




1. Sagirli O, Cetin SM, Onal A. Determination of gabapentin in human plasma and urine by high-performance liquid chromatography with UV–Vis detection. J. Pharm. Biomed. Anal. 2006; 42: 618.
2. Eduardo AJ, Duarte LF, Pereira R, Pozzebon JM, Tosetti D and Cardoso Custodio JM. Gabapentin Bioequivalence Study: Quantification by Liquid Chromatography Coupled to Mass Spectrometry. J. Bioeq. Avail. 2011; 3(8):187.
3. Gupta A, Ciavarella AB, Sayeed VA, Khan MA, Faustino PJ. Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products. J. Pharm. Biomed. Anal. 2008; 46 (1):181.
4. Ciavarella AB, Gupta A, Sayeed VA, Khan, MA, Faustino PJ. Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products. J. Pharm. Biomed. Anal. 2007; 43 (5): 1647.
5. Vermeij TA, Edelbroek PM. Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phtaldialdehyde and fluorescence detection. J. Chromatogr. B 2004; 810 (2): 297.
6. Wad N, Kramer G. Sensitive high-performance liquid chromatographic method with fluorometric detection for the simultaneous determination of gabapentin and vigabatrin in serum and urine. J. Chromatogr B: Biomed. Sci. Appl. 1998; 705 (1): 154.
7. Bahrami G, Mohammadi B. Sensitive microanalysis of gabapentin by high-performance liquid chromatography in human serum using pre-column derivatization with 4-chloro-7-nitrobenzofurazan: Application to a bioequivalence study. J. Chromatogr. B 2006; 837:24.
8. Zhu Z, Neirinck L. High-performance liquid chromatographic method for the determination of gabapentin in human plasma. J. Chromatogr. B 2002; 779 (2):307.
9. Amini M, Rouini MR, Asad-Paskeh A, Abbas Shafiee. A new pre-column derivatization method for determination of gabapentin in human serum by HPLC using UV detection. J. Chromatogr. Sci. 2010; 48:358.
10. Chang SY, Wang FY. Determination of gabapentin in human plasma by capillary electrophoresis with laser-induced fluorescence detection and acetonitrile stacking technique. J. Chromatogr. B 2004; 799 (2):265.
11. Wolf WE, Saady JJ, Poklis A. Determination of Gabapentin in Serum Using Solid-Phase Extraction and Gas-Liquid Chromatography. J. Anal. Toxicol. 1996; 20:498.
12. Kushnir MM, Crossett J, Brown PI and Urry FM. Analysis of Gabapentin in Serum and Plasma by Solid-Phase Extraction and Gas Chromatography- Mass Spectrometry for Therapeutic Drug Monitoring. J. Anal. Toxicol. 1999; 23:1.
13. Gambelunghe C, Mariucci G, Tantucci M, Amboina MV. Gas chromatography–tandem mass spectrometry analysis of gabapentin in serum. Biomed. Chromatogr. 2005; 19:63.
14. Van Lente F, Gatautis V. Cost-efficient Use of Gas Chromatography–Mass Spectrometry: A Piggyback” Method for Analysis of Gabapentin. Clin. Chem. 1998; 44 (9):2044.
15. Abdel C, Arno S, Jeroen GB, Rene VM. Rapid Quantification of Gabapentin, Pregabalin, and Vigabatrin in Human Serum by ultra performance liquid chromatography with Mass-Spectrometric Detection. Therap. Drug Monit. 2013; 35(1):48.
16. Park J, Jhee OH. Validated LC-MS/MS method for quantification of gabapentin in human plasma: application to pharmacokinetic and bioequivalence studies in Korean volunteers. Biomed. Chromatogr. 2007; 21(8):829.
17. Ramakrishna NVS, Vishwottam KN, Koteshwara M, Manoj S, Santosh M, Chidambara J, Sumatha B, Varma DP. Rapid quantification of gabapentin in human plasma by liquid chromatography/tandem mass spectrometry. J of Pharm. Biomed. Anal. 2006; 40 (2): 360.
18. Carlsson KC, Reubsaet JLE. Sample preparation and determination of gabapentin in venous and capillary blood using liquid chromatography–tandem mass spectrometry. J Pharm. Biomed. Anal. 2004; 34 (2): 415.
19. Ying Liu. Analysis of Gabapentin in Equine Plasma with Measurement Uncertainty Estimation by Liquid Chromatography–Tandem Mass Spectrometry. J Anal. Toxicol. 2011; 35:75.
20. Guidance for Industry, Bioanalytical Method validation, CDER, May 2001
810 Views | 540 Downloads
How to Cite
BINAYA, D. “ESTIMATION OF GABAPENTIN IN HUMAN PLASMA USING LC-MS/MS METHOD”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 6, no. 7, Aug. 2013, pp. 213-6,